Product Wiki · Recalls · Health Canada — Medical Devices

Pipeline™ Vantage Embolization Device With Shield Technology™ — recall 76889

Health Canada — Medical Devices · Canada · 2025-02-03 · Type I

Compiled from an official source — the facts on this page are reproduced from the issuing authority’s own published notice, which is linked above. No AI-generated text appears on this page. How we use AI →
Agency
Health Canada — Medical Devices
Recall identifier
76889
Date of alert
2025-02-03
Country / jurisdiction
Canada
Risk level
Type I
Risk type
recall
Product category
Cardiovascular
Product type
Medical devices
Reported risk: Medtronic is initiating a recall of Pipeline™ Vantage devices with the part numbers PED3-027-XXX-XX, which represents compatibility to 0.027 inch (0.69 mm) inner diameter (id) microcatheters ["Pipeline™ Vantage 027"]. Additionally, Medtronic is issuing a correction to the IFY of pipeline vantage devices with the part number PED3-021-XXX-XX, which represents compatibility to 0.021 inch (0.53 mm) inner diameter (id) microcatheters ["Pipeline™ Vantage 021"]. Medtronic has received reports of incomplete wall apposition and/or braid deformation noted during the procedure and post procedure involving the Pipeline™ Vantage 027 and Pipeline™ Vantage 021 devices. Braid deformation (sometimes termed "fishmouthing", "braid narrowing", or "braid collapse") and incomplete wall apposition are known risks that potentially can lead to thrombosis and/or serious adverse events including stroke or death. As of 31 December 2024, Medtronic has received reports of incomplete wall apposition and/or braid deformation, including 3 patient deaths and 13 ischemic strokes (from 416 complaints out of approximately 18,200 Pipeline™ Vantage 027 units distributed worldwide). Pipeline™ Vantage 027 devices (diameters ≥4mm) appear to exhibit a higher incidence stent braid deformation compared to the pipeline shield. Additionally, the risk of braid deformation was higher in females, especially females ≤45 years of age. the risk of braid deformation presents either intra-operatively or post-procedurally, with braid deformations typically noted at 6-12-month imaging follow-up. Comparatively, for Pipeline™ Vantage 021 devices, fewer reports were received for incomplete wall apposition and/or braid deformation with 0 deaths and 4 strokes (from 57 complaints out of approximately 7,400 units distributed). The Pipeline™ Vantage 021 compatible sizes are similar to the pipeline shield product family in design characteristics. The rate of braid deformation for the Pipeline™ Vantage 021 is lower than that observed for Pipeline™ Vantage 027. Based on this information, the removal (retrieval) is only isolated unused inventory of the Pipeline™ Vantage 027 devices. As part of this recall, Medtronic will correct the IFU of the Pipeline™ Vantage 021 to provide instructions to users on mitigating the risk of incomplete wall apposition and/or braid deformation. Recall start date: January 30, 2025
Primary source: https://recalls-rappels.canada.ca/en/alert-recall/pipelinetm-vantage-embolizatio

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.